T. Rowe Price Investment Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2M | Buy |
2,473,956
+45,673
| +2% | +$520K | 0.02% | 457 |
|
|
2025
Q1 | $28.8M | Buy |
2,428,283
+47,855
| +2% | +$569K | 0.02% | 475 |
|
|
2024
Q4 | $44.8M | Sell |
2,380,428
-167,663
| -7% | -$3.16M | 0.03% | 424 |
|
|
2024
Q3 | $57.3M | Buy |
2,548,091
+358,899
| +16% | +$8.06M | 0.03% | 383 |
|
|
2024
Q2 | $45.7M | Buy |
+2,189,192
| New | +$45.7M | 0.03% | 398 |
|
|
2023
Q1 | – | Sell |
-432,161
| Closed | -$4.75M | – | 560 |
|
|
2022
Q4 | $4.75M | Sell |
432,161
-560,267
| -56% | -$6.15M | ﹤0.01% | 524 |
|
|
2022
Q3 | $12.9M | Buy |
+992,428
| New | +$12.9M | 0.01% | 485 |
|